TapewireFind a company

person · Reporting owner

Lofton Kevin E

Disclosed activity across 4 companies

Tapewire entity
15232
SEC CIK
0001468818

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
GILEAD SCIENCES, INC.GILD · Entity 405DirectorMarch 28, 2024March 29, 2024
Medtronic plcMDT · Entity 2888DirectorApril 27, 2026April 29, 2026
MiniMed Group, Inc.MMED · Entity 3758DirectorOctober 09, 2026October 13, 2026
NEW RITE AID, LLCRAD · Entity 87704DirectorJuly 07, 2021July 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GILEAD SCIENCES, INC.

Report date March 28, 2024 · Filed March 29, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct3,258.1388 Reported balance After 2024-03-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-03-28 · Grant · Acquired 33.8931 · Balance 3,258.1388

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Medtronic plc

Report date April 27, 2026 · Filed April 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect10,347 Reported balance After 2026-04-27 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-04-27 · Grant · Acquired 2,111 · Balance 10,347

F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

F2: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Ordinary SharesSEC Table I · non-derivativeDirect10,140 Reported balance After 2026-04-28 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2026-04-28 · Tax withholding · Disposed 207 · Balance 10,140

F3: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

F2: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person.

F3: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

MiniMed Group, Inc.

Report date October 09, 2026 · Filed October 13, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect39,573 Reported balance After 2026-10-09 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-10-09 · Grant · Acquired 11,795 · Balance 39,573

F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.

F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.

F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

NEW RITE AID, LLC

Report date July 07, 2021 · Filed July 09, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect45,943 Reported balance After 2021-07-07 transaction · row 1
1 source row

Row 1 · 2021-07-07 · Grant · Acquired 10,617 · Balance 45,943

F1: Grant of restricted stock exempt from Section 16(b) under Rule 16b-(3)(d).

Common StockSEC Table I · non-derivativeIndirectBy Spouse250 Reported balance Holding disclosure · report date 2021-07-07 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 250

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted stock exempt from Section 16(b) under Rule 16b-(3)(d).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 05, 2020 Filed May 8, 2020 00:20 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 2,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-015840 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Read SEC document
March 30, 2020 Filed Apr 1, 2020 18:16 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 24.5203 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-012368 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,762.4998

Underlying: Common Stock · 24.5203 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
February 24, 2020 Filed Feb 25, 2020 22:13 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 21,720 $0.00 Strike: $19.63 $0.00
Disclosure

SEC source: 0001127602-20-007698 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,720 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 11, 2011.

Read SEC document
February 24, 2020 Filed Feb 25, 2020 22:13 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 21,720 $19.63 $426,363.60
Disclosure

SEC source: 0001127602-20-007698 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:19 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 26.3107 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-000153 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,737.9795

Underlying: Common Stock · 26.3107 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
November 27, 2019 Filed May 20, 2020 23:13 UTC GILEAD SCIENCES, INC. GILD · Entity 405 OtherCommon Stock 13,208 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-017427 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,641

F1 · shares: Gifted to a charitable trust.

Read SEC document
October 01, 2019 Filed Oct 4, 2019 01:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 21,527 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-030082 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,711

Underlying: Common Stock · 21,527 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · shares: An aggregate of 21527.606841 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.606841 was paid out in cash in connection with the conversion into shares of common stock.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
October 01, 2019 Filed Oct 4, 2019 01:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 21,527 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-030082 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,859

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 00:00 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 240.3706 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-029284 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,239.2756

Underlying: Common Stock · 240.3706 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 17, 2019 Filed Jul 19, 2019 16:19 UTC NEW RITE AID, LLC RAD · Entity 87704 GrantCommon Stock 15,400 $7.79 $119,966.00
Disclosure

SEC source: 0001209191-19-042783 · doc4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,645

Read SEC document
June 27, 2019 Filed Jul 1, 2019 23:43 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 223.2951 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-023301 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,998.9051

Underlying: Common Stock · 223.2951 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 27, 2019 Filed Jul 1, 2019 23:48 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 223.2951 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-023303 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,998.9051

Underlying: Common Stock · 223.2951 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 08, 2019 Filed May 10, 2019 21:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 11,848 $0.00 Strike: $66.07 $0.00
Disclosure

SEC source: 0001127602-19-018184 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,848

Underlying: Common Stock · 11,848 shares

Expires 2029-05-08

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 08, 2019 Filed May 10, 2019 21:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-018184 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,164

Underlying: Common Stock · 2,270 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
April 24, 2019 Filed Apr 25, 2019 22:51 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 13,208 $0.00 Strike: $24.91 $0.00
Disclosure

SEC source: 0001127602-19-016247 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,208 shares

Expires 2019-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on July 29, 2010.

Read SEC document
April 24, 2019 Filed Apr 25, 2019 22:51 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 13,208 $24.91 $328,945.24
Disclosure

SEC source: 0001127602-19-016247 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 28, 2019 Filed Apr 1, 2019 23:19 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 232.8768 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-013911 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,775.61

Underlying: Common Stock · 232.8768 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
February 20, 2019 Filed Feb 22, 2019 15:26 UTC NEW RITE AID, LLC RAD · Entity 87704 GrantCommon Stock 155,844 $0.77 $119,999.88
Disclosure

SEC source: 0001209191-19-012500 · doc4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,918

Read SEC document
December 28, 2018 Filed Jan 2, 2019 22:17 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 214.8816 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-000349 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,542.7332

Underlying: Common Stock · 214.8816 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 27, 2018 Filed Oct 1, 2018 22:53 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 172.3509 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-028857 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,327.8516

Underlying: Common Stock · 172.3509 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 01, 2018 Filed Jul 3, 2018 20:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 1,623 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-022667 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,155.5006

Underlying: Common Stock · 1,623 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 28, 2018 Filed Jul 2, 2018 23:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 173.1104 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-022354 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,532.5006

Underlying: Common Stock · 173.1104 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 09, 2018 Filed May 11, 2018 23:09 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-18-017240 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,894

Underlying: Common Stock · 2,283 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 09, 2018 Filed May 11, 2018 23:09 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 9,496 $0.00 Strike: $65.69 $0.00
Disclosure

SEC source: 0001127602-18-017240 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,496

Underlying: Common Stock · 9,496 shares

Expires 2028-05-09

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 23:43 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 160.2798 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-013418 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,359.3902

Underlying: Common Stock · 160.2798 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 23:26 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 151.0074 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-000216 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,199.1105

Underlying: Common Stock · 151.0074 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 28, 2017 Filed Oct 3, 2017 00:15 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 134.4101 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-028710 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,048.1031

Underlying: Common Stock · 134.4101 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 17, 2017 Filed Sep 20, 2017 12:27 UTC NEW RITE AID, LLC RAD · Entity 87704 GrantCommon Stock 51,984 $0.00 $0.00
Disclosure

SEC source: 0001712805-17-000005 · edgardoc.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,074

Read SEC document
July 01, 2017 Filed Jul 5, 2017 21:49 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 1,624 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023032 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,913.693

Underlying: Common Stock · 1,624 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 17:06 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 140.5245 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-022504 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,289.693

Underlying: Common Stock · 140.5245 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 10, 2017 Filed May 12, 2017 21:36 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,241 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-017967 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,611

Underlying: Common Stock · 2,241 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 10, 2017 Filed May 12, 2017 21:36 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 10,376 $0.00 Strike: $66.92 $0.00
Disclosure

SEC source: 0001127602-17-017967 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,376

Underlying: Common Stock · 10,376 shares

Expires 2027-05-10

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 09, 2017 Filed May 11, 2017 22:31 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionRestricted Stock Unit · Derivative 1,787 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-017794 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,370

Underlying: Common Stock · 1,787 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 9, 2017.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 9, 2017.

Read SEC document
May 09, 2017 Filed May 11, 2017 22:31 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 1,787 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-017794 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc. common stock.

Read SEC document
March 30, 2017 Filed Apr 3, 2017 22:20 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 146.3272 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-013647 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,149.1685

Underlying: Common Stock · 146.3272 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 29, 2016 Filed Jan 4, 2017 00:41 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 123.0211 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-000370 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,002.8413

Underlying: Common Stock · 123.0211 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 29, 2016 Filed Oct 4, 2016 00:00 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 113.2837 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-063784 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,879.8201

Underlying: Common Stock · 113.2837 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
August 24, 2016 Filed Aug 25, 2016 21:05 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 3,500 $81.97 $286,898.85
Disclosure

SEC source: 0001127602-16-061156 · form4.xml · nonDerivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 0

F2 · price: Sale prices reported for the transaction reported here range from $81.97 to $81.98. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F1 · ownership.direct: Shares acquired by marriage.

Read SEC document
June 29, 2016 Filed Jul 1, 2016 17:47 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 106.6023 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-056787 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,766.5364

Underlying: Common Stock · 106.6023 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are full vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are full vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 21, 2016 Filed Aug 25, 2016 21:05 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantCommon Stock 3,500 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-061156 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 3,500

F1 · ownership.direct: Shares acquired by marriage.

Read SEC document
May 11, 2016 Filed May 13, 2016 23:44 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 7,321 $0.00 Strike: $83.90 $0.00
Disclosure

SEC source: 0001127602-16-052228 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,321

Underlying: Common Stock · 7,321 shares

Expires 2026-05-11

F3 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 11, 2016 Filed May 13, 2016 23:44 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 1,787 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-16-052228 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,157

Underlying: Common Stock · 1,787 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:00 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 86.8373 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-048105 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,659.934

Underlying: Common Stock · 86.8373 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are full vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are full vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 30, 2015 Filed Jan 4, 2016 23:42 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 77.8481 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-16-016959 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573.0967

Underlying: Common Stock · 77.8481 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 29, 2015 Filed Oct 1, 2015 20:47 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 82.4739 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-013513 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,495.2487

Underlying: Common Stock · 82.4739 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 01, 2015 Filed Jul 6, 2015 20:49 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 991 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-010922 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,412.7748

Underlying: Common Stock · 991 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2015 Filed Jul 1, 2015 22:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 64.6448 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-010627 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,421.7748

Underlying: Common Stock · 64.6448 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 06, 2015 Filed May 7, 2015 21:13 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-Qualified Stock Options (Right to Buy) · Derivative 5,167 $0.00 Strike: $102.27 $0.00
Disclosure

SEC source: 0001179110-15-007265 · edgar.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

Underlying: Common Stock · 5,167 shares

Expires 2025-05-06

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 06, 2015 Filed May 7, 2015 21:13 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Units · Derivative 1,466 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-15-007265 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,370

Underlying: Common Stock · 1,466 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
July 01, 2014 Filed Jul 2, 2014 20:25 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 1,011 $0.00 $0.00
Disclosure

SEC source: 0001179110-14-011277 · edgar.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,355

Underlying: Common Stock · 1,011 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.